Global Orthostatic Hypotension Market Growth Trends and Revenue Forecast
According to a newly published market research report by 24LifeSciences, global orthostatic hypotension market was valued at USD 1.36 billion in 2024 and is projected to reach USD 2.18 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.9% during the forecast period 2025–2031.
Orthostatic hypotension (OH), clinically defined as a reduction of systolic blood pressure of at least 20 mm Hg or diastolic blood pressure of at least 10 mm Hg within three minutes of standing, is a common cardiovascular disorder often associated with dizziness, lightheadedness, and syncope. This condition significantly impacts patient quality of life and increases fall risk, particularly in the geriatric population, with prevalence estimated at over 30% in adults aged 70 and older. Its management is crucial within neurology and cardiology, driven by its connection to neurodegenerative diseases, diabetes, and cardiovascular ailments.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/8962/orthostatic-hypotension-market
Global Orthostatic Hypotension Market Growth Trends and Revenue Forecast
According to a newly published market research report by 24LifeSciences, global orthostatic hypotension market was valued at USD 1.36 billion in 2024 and is projected to reach USD 2.18 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.9% during the forecast period 2025–2031.
Orthostatic hypotension (OH), clinically defined as a reduction of systolic blood pressure of at least 20 mm Hg or diastolic blood pressure of at least 10 mm Hg within three minutes of standing, is a common cardiovascular disorder often associated with dizziness, lightheadedness, and syncope. This condition significantly impacts patient quality of life and increases fall risk, particularly in the geriatric population, with prevalence estimated at over 30% in adults aged 70 and older. Its management is crucial within neurology and cardiology, driven by its connection to neurodegenerative diseases, diabetes, and cardiovascular ailments.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/8962/orthostatic-hypotension-market
According to a newly published market research report by 24LifeSciences, global orthostatic hypotension market was valued at USD 1.36 billion in 2024 and is projected to reach USD 2.18 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.9% during the forecast period 2025–2031.
Orthostatic hypotension (OH), clinically defined as a reduction of systolic blood pressure of at least 20 mm Hg or diastolic blood pressure of at least 10 mm Hg within three minutes of standing, is a common cardiovascular disorder often associated with dizziness, lightheadedness, and syncope. This condition significantly impacts patient quality of life and increases fall risk, particularly in the geriatric population, with prevalence estimated at over 30% in adults aged 70 and older. Its management is crucial within neurology and cardiology, driven by its connection to neurodegenerative diseases, diabetes, and cardiovascular ailments.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/8962/orthostatic-hypotension-market
Global Orthostatic Hypotension Market Growth Trends and Revenue Forecast
According to a newly published market research report by 24LifeSciences, global orthostatic hypotension market was valued at USD 1.36 billion in 2024 and is projected to reach USD 2.18 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.9% during the forecast period 2025–2031.
Orthostatic hypotension (OH), clinically defined as a reduction of systolic blood pressure of at least 20 mm Hg or diastolic blood pressure of at least 10 mm Hg within three minutes of standing, is a common cardiovascular disorder often associated with dizziness, lightheadedness, and syncope. This condition significantly impacts patient quality of life and increases fall risk, particularly in the geriatric population, with prevalence estimated at over 30% in adults aged 70 and older. Its management is crucial within neurology and cardiology, driven by its connection to neurodegenerative diseases, diabetes, and cardiovascular ailments.
Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/8962/orthostatic-hypotension-market
0 Comments
·0 Shares
·41 Views
·0 Reviews
